Vedolizumab for treating moderate to severe active Crohn's disease after prior therapy [ID690]

Rafia R, Scope A, Harnan S, Stevens JW, Stevenson M, Sutton A, Dickinson K, Parkes M, Mayberry J, Lobo A
Record ID 32015000758
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Antibodies, Monoclonal, Humanized
  • Anti-Inflammatory Agents
  • Treatment Failure
  • Remission Induction
  • Glucocorticoids
  • Immunosuppressive Agents
  • Colitis, Ulcerative
  • Crohn Disease
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
Contact Email:
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.